Chronic renal failure overview

Jump to navigation Jump to search
https://https://www.youtube.com/watch?v=E1myFSlpy-A%7C350}}

Chronic renal failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic renal failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic renal failure overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic renal failure overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic renal failure overview

CDC on Chronic renal failure overview

Chronic renal failure overview in the news

Blogs on Chronic renal failure overview

Directions to Hospitals Treating Chronic renal failure

Risk calculators and risk factors for Chronic renal failure overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

Chronic renal failure (CRF), also known as chronic kidney failure (CKF) or chronic kidney disease (CKD), or chronic renal insufficiency (CRI) is a slowly progressive loss of renal function over a period of months or years defined as an abnormally low glomerular filtration rate. The glomerular filtration rate is usually determined indirectly by the creatinine level in blood serum.

CRF that leads to severe illness and requires some form of renal replacement therapy (such as dialysis) is called end-stage renal disease (ESRD).

Definition

  • CKD is defined as:
    • Presence of markers of kidney damage for > 3 months, and may include abnormalities in markers in blood or urine, and imaging tests.
    • GFR < 60 mL/min/1.73 m2 for > 3 months with or without other signs of kidney damage.

Pathophysiology

CRF begins with damage to the nephrons, the filtering units of the kidneys, due to diseases such as diabetes, hypertension, immune complex deposition, toxin exposure, and inflammation. To compensate for the decreased glomerular filtration rate by the damaged nephrons, healthy nephrons hypertrophy and start hyperfiltrating due to signals from the body. As the disease process progresses, this adaptive response becomes maladaptive, and the increased filtration pressure in the healthy nephrons leads to the distortion of its structural architecture, causing sclerosis and eventual dropout of these nephrons.

Epidemiology and Demographics

The incidence and prevalence of chronic renal failure varies enormously depending on the level of affluence of the country. Developed countries have higher incident rates of treated end-stage renal failure, whereas emerging countries have very low incident rates. People with disorders that have adverse effects on the kidneys such as diabetes, and hypertension have increased chances of developing CRF.

Risk Factors

Disorders or habits that damage small blood vessels or the nephrons are risk factors for developing chronic renal failure. Some of the factors associated with CRF include diabetes, hypertension, autoimmune diseases, obesity, smoking, high cholesterol, heart disease, and racial background.

Causes

CRF is associated with diseases such as diabetic nephropathy, hypertension, glomerulonephritis, ischemic nephropathy, vasculitis, Hemolytic-uremic syndrome, IgA nephropathy, and polycystic kidney disease to name a few. Diseases of the blood vessels or diseases that damage the nephrons are usually linked to the development of CRF.

Differentiating Chronic renal failure from other Conditions

CRF can be discerned from acute renal failure by looking at the timeline of the rise of serum creatinine levels. Acute renal failure is identified by sharp rises in the levels of creatinine, while CRF is identified by a slow and gradual increase in serum creatinine.

Natural History, Complications and Prognosis

Repeated episodes of acute renal injury from infections, drugs, toxins and immunological damage may accelerate the progression to chronic renal failure, especially in the elderly. Once CRF is developed, the condition can cause systemic problems such as infertility, myopathy, sleep disorders, pruritis, congestive heart failure, and pulmonary edema amongst other problems. The prognosis and quality of life for a patient with CRF is poor. Data indicates that the overall death rate increases as kidney function decreases.

Diagnosis

Symptoms

Some symptoms of CRF include: malaise, pruritus, headaches, drowsiness, numbness of the hands and feet, vomiting, bone pain, abnormally dark or light skin, and sleep disorders to name a few.

Physical Examination

Chronic renal failure causes disturbances not only in the filtration function of the kidney, but also in the normal functioning of virtually every organ in the body. Symptoms and overt signs of kidney disease are often subtle or are absent until renal failure ensues. Thus, the diagnosis of chronic renal failure often takes the patient by surprise and may cause denial.

Laboratory Studies

The kidneys play an important role in the regulation of serum concentration of sodium, potassium, calcium, phosphate, bicarbonate and chloride as well as levels of hemoglobin, hematocrit, blood pressure and extracellular volume. Hence, chronic injury to the kidneys can lead to abnormalities in the stable values of the above mentioned parameters.

Treatment

Treatment is aimed at specific causes of chronic renal failure. It includes optimized glucose levels in patients with diabetes, management of blood pressure, immunomodulators for glomerulonephritis, emerging specific therapies to retard cytogenesis in polycystic kidney disease and replacement of critical hormones and chemicals produced and utilized by normally healthy kidneys. Any acceleration in the disease process should prompt a search for superimposed acute or subacute disease process that is potentially reversible. These include extravascular fluid volume depletion, urinary tract infection, obstructive uropathy, exposure to nephrotoxic agents such as NSAIDs or radiocontrasts, re-activation and flare of the primary disease like SLE or vasculitis.

References


Template:WH Template:WS